Oncology Drug Development in Practice (ODDP) is an educational program designed for professionals in academia and industry who wish to acquire or expand their knowledge of drug development in oncology.
ODDP 2018 is a 3-day educational program that serves several target audiences:
• Anyone looking for a solid introduction into the essentials of oncology will benefit from participating in part A;
• Drug development professionals in industry and academia wishing to acquire or expand knowledge of oncology drug development will benefi t from participating in parts A and B combined or part B only, depending on their starting level of oncology knowledge.

Parts A (day 1) and B (days 2 and 3) may be booked separately or combined. For successful participation in either part, an understanding of the basic principles of biology and medicine at the graduate level is recommended. Pre-reading materials will be provided to registered participants well before the start of the course

ODDP offers education on tumor biology, pathology, various domains of cancer patient management, anticancer drug development, with a focus on the situation in Europe and a number of associated areas.

This education will be presented by experts from leading academic research institutes and oncologyorientated drug companies, all having ampleexpertise and hands-on experience in cancer research, clinical oncology, and/or anticancer drug development.

Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

Scoop Line(Instant Information Request)The easiest way to ask questions and request information from the PR community.

Advanced SearchDrill down, dig deep, for media information the way you want it.